OBJECTIVE: Nogo-A is an axon regeneration inhibitor, and its function in central nervous system (CNS) is still unknown. The present study is to explore the relationship between the expression of Nogo-A and the malignancy of oligodendroglial tumors in patients. METHODS: Tumor tissue samples with different malignancy grade were obtained from the hospitals. The samples used for detection had been diagnosed as oligodendroglial tumors (oligodendroglioma or anaplastic oligodendroglioma). The expression of Nogo-A was detected by immunohistochemistry and western-blot analysis. The correlation test between the Nogo-A expression and the morphological changes (the percentages of atypical cells and mitotic cells in the tumors) related to the malignancy of tumor tissues was performed. RESULTS: There was significant negative correlation between the Nogo-A expression and the morphological change of tumor tissues according to immunohistochemistry. Western-blot analysis also indicated that the gray value of Nogo-A protein band in the oligodendroglioma group was significantly higher than that in the anaplastic oligodendroglioma group. CONCLUSION: Nogo-A expression was negatively correlated with the malignancy grade of oligodendroglial tumors.
OBJECTIVE:Nogo-A is an axon regeneration inhibitor, and its function in central nervous system (CNS) is still unknown. The present study is to explore the relationship between the expression of Nogo-A and the malignancy of oligodendroglial tumors in patients. METHODS:Tumor tissue samples with different malignancy grade were obtained from the hospitals. The samples used for detection had been diagnosed as oligodendroglial tumors (oligodendroglioma or anaplastic oligodendroglioma). The expression of Nogo-A was detected by immunohistochemistry and western-blot analysis. The correlation test between the Nogo-A expression and the morphological changes (the percentages of atypical cells and mitotic cells in the tumors) related to the malignancy of tumor tissues was performed. RESULTS: There was significant negative correlation between the Nogo-A expression and the morphological change of tumor tissues according to immunohistochemistry. Western-blot analysis also indicated that the gray value of Nogo-A protein band in the oligodendroglioma group was significantly higher than that in the anaplastic oligodendroglioma group. CONCLUSION:Nogo-A expression was negatively correlated with the malignancy grade of oligodendroglial tumors.
Authors: Thomas Oertle; Marjan E van der Haar; Christine E Bandtlow; Anna Robeva; Patricia Burfeind; Armin Buss; Andrea B Huber; Marjo Simonen; Lisa Schnell; Christian Brösamle; Klemens Kaupmann; Rüdiger Vallon; Martin E Schwab Journal: J Neurosci Date: 2003-07-02 Impact factor: 6.167
Authors: Q Li; B Qi; K Oka; M Shimakage; N Yoshioka; H Inoue; A Hakura; K Kodama; E J Stanbridge; M Yutsudo Journal: Oncogene Date: 2001-07-05 Impact factor: 9.867
Authors: M S Chen; A B Huber; M E van der Haar; M Frank; L Schnell; A A Spillmann; F Christ; M E Schwab Journal: Nature Date: 2000-01-27 Impact factor: 49.962
Authors: Mohamed T Ghorbel; Greig Sharman; Marie Leroux; Tanya Barrett; David M Donovan; Kevin G Becker; David Murphy Journal: J Biol Chem Date: 2003-03-14 Impact factor: 5.157
Authors: Thomas Wälchli; Alexandra Ulmann-Schuler; Christoph Hintermüller; Eric Meyer; Marco Stampanoni; Peter Carmeliet; Maximilian Y Emmert; Oliver Bozinov; Luca Regli; Martin E Schwab; Johannes Vogel; Simon P Hoerstrup Journal: J Cereb Blood Flow Metab Date: 2016-11-13 Impact factor: 6.200
Authors: Thomas Wälchli; Vincent Pernet; Oliver Weinmann; Jau-Ye Shiu; Anna Guzik-Kornacka; Guillaume Decrey; Deniz Yüksel; Hannah Schneider; Johannes Vogel; Donald E Ingber; Viola Vogel; Karl Frei; Martin E Schwab Journal: Proc Natl Acad Sci U S A Date: 2013-04-26 Impact factor: 11.205